Litigation Details for Cellspin Soft, Inc. v. Fitbit LLC (Fed. Cir. 2022)

« Back to Dashboard

Cellspin Soft, Inc. v. Fitbit LLC (Fed. Cir. 2022)

Docket	22-2025	Date Filed	2022-07-15
Court	Court of Appeals for the Federal Circuit	Date Terminated	2024-11-01
Cause		Assigned To
Jury Demand		Referred To
Patents	10,124,014
Link to Docket	External link to docket

Details for Cellspin Soft, Inc. v. Fitbit LLC (Fed. Cir. 2022)

Date Filed	Document No.	Description	Snippet	Link To Document
2022-07-15				External link to document

Cellspin Soft v. Fitbit, 22-2025: Patent Litigation Summary and Section 101 Analysis

Last updated: October 28, 2026

Cellspin Soft, Inc. v. Fitbit LLC, No. 22-2025, was a Federal Circuit appeal concerning whether four Cellspin wireless-sensor patents claimed patent-eligible technology under 35 U.S.C. § 101. The Federal Circuit reversed the district court’s dismissal and held that Cellspin’s amended complaint plausibly alleged an inventive concept at Alice step two. The decision allowed the infringement case to proceed beyond the pleadings stage. It did not hold that the patents were valid, infringed, or immune from later invalidity challenges.

The case is important for software and connected-device patent litigation because the Federal Circuit treated the claimed ordered combination of sensor, mobile-device, and server communications as potentially inventive, even though individual components were conventional computing technologies. The ruling limited early dismissal where the patent specification and complaint identify a specific technical improvement in wireless data transmission. [1]

What patents were at issue in Cellspin Soft v. Fitbit?

Cellspin asserted four patents relating to wireless sensors, mobile devices, and remote data transmission:

Patent	General subject matter	Litigation role
U.S. Patent No. 8,738,794	Wireless sensor data communication	Asserted patent
U.S. Patent No. 9,258,698	Sensor-to-mobile-device data transmission	Asserted patent
U.S. Patent No. 9,749,847	Wireless sensor and mobile-device communications	Asserted patent
U.S. Patent No. 10,951,734	Related wireless data communication techniques	Asserted patent

The asserted patents generally describe systems in which a wireless sensor communicates with a mobile device, which then transmits sensor data to a remote server. The claims were directed to the interaction and sequencing of these components rather than to a new physical sensor or a new type of network hardware.

Cellspin alleged that Fitbit’s accused products practiced the claimed techniques through wearable devices, mobile applications, and cloud services.

What technology did the Cellspin patents claim?

The asserted claims focused on the acquisition, processing, and transmission of sensor data through a wireless architecture. The claimed system used a sensor, a mobile device, and a remote server. The mobile device was positioned between the sensor and server and performed specified communication steps.

Cellspin’s patent specifications identified technical problems associated with wireless sensor systems, including delayed establishment of communications, inefficient data transfer, and the need to transmit sensor information through a mobile device to a server. The Federal Circuit treated those stated problems and the claimed sequence of operations as relevant to the § 101 analysis.

What was the procedural history of Cellspin v. Fitbit?

Cellspin sued Fitbit and other defendants in the U.S. District Court for the Northern District of California. Fitbit moved to dismiss under Federal Rule of Civil Procedure 12(b)(6), arguing that the asserted claims were directed to patent-ineligible abstract ideas.

The district court granted dismissal under § 101. It characterized the claims as directed to the abstract idea of collecting, communicating, and transmitting data. The court concluded that the claims did not add an inventive concept sufficient to transform that abstract idea into patent-eligible subject matter.

Cellspin appealed to the Federal Circuit under docket No. 22-2025.

What did the Federal Circuit decide?

The Federal Circuit reversed the dismissal and remanded the case. The court held that Cellspin had plausibly alleged that the claims included an inventive concept. The decision was based on the sufficiency of the pleadings, not a final determination of patent validity.

The court’s analysis emphasized that the claims required more than the generic use of a sensor, mobile device, and server. According to the Federal Circuit, the claims recited a specific ordered combination of operations that addressed a problem in wireless data communication.

The ruling allowed Cellspin to continue pursuing its infringement claims. Fitbit retained the ability to challenge validity at later stages through summary judgment, claim construction, expert testimony, or trial.

Why did the Federal Circuit reverse the § 101 dismissal?

The Federal Circuit’s reasoning centered on three points.

Did the claims recite more than generic data collection?

Yes. The court held that the claims plausibly recited a specific method of transferring sensor data through a mobile device and remote server. The claims were not analyzed solely as a high-level instruction to collect and transmit information.

The court distinguished claims that merely state a desired result from claims that describe a particular implementation. Cellspin’s allegations tied the claims to a particular wireless architecture and sequence of communications.

Did the patent specification identify a technical problem?

Yes. The specification described problems involving the timing and establishment of communications between wireless sensors and mobile devices. Cellspin alleged that its claimed approach improved the operation of the system by establishing communications in a particular sequence before the relevant sensor data was transmitted.

That relationship between the technical problem and the claimed solution supported Cellspin’s allegation that the claims contained an inventive concept.

Could conventional components form a patent-eligible combination?

Yes. The fact that sensors, mobile devices, servers, and wireless communications were individually known did not resolve the § 101 inquiry. The relevant question was whether the claimed combination and arrangement were conventional.

The Federal Circuit stated that an ordered combination of conventional elements can satisfy Alice step two when the combination itself is unconventional or improves the operation of the technology. [1]

How did the Alice framework apply to Cellspin’s patents?

The Federal Circuit applied the two-step framework established by Alice Corp. v. CLS Bank International and Mayo Collaborative Services v. Prometheus Laboratories.

Alice step	Court’s treatment
Step one	The claims could be viewed as involving the collection and transmission of sensor data, but the analysis could not ignore the specific claimed arrangement and sequence.
Step two	Cellspin plausibly alleged that the ordered combination improved wireless communications and was not conventional.
Procedural posture	The issue was decided on a motion to dismiss, before claim construction and discovery.
Result	Dismissal was reversed and the case was remanded.

The decision did not eliminate the eligibility issue. It held only that the complaint contained sufficient allegations to survive dismissal.

What was the main legal significance of the decision?

The decision reinforced several Federal Circuit principles relevant to connected-device patent cases.

First, courts must evaluate the claims as a whole. A claim may be improperly abstracted if the analysis reduces it to a broad functional description such as “collecting and transmitting data.”

Second, the patent specification can be relevant to whether a claimed arrangement provides a technical improvement. The specification does not replace the claim, but it can explain why the claimed sequence is technically different from routine data processing.

Third, the procedural posture matters. At the Rule 12(b)(6) stage, the court must accept well-pleaded allegations as true and draw reasonable inferences in the patentee’s favor. A defendant may still prevail later if the undisputed record shows that the claimed combination was conventional.

Fourth, the ruling reflects a distinction between generic computer implementation and a particular communications architecture. The Federal Circuit accepted that the distinction could be material even though the claims used known hardware components.

What was the status of the litigation after the Federal Circuit ruling?

The Federal Circuit reversed the district court’s dismissal and remanded the case for further proceedings. The appellate opinion did not record a final judgment of infringement or validity.

The decision therefore left several issues open:

• Whether the asserted claims would survive claim construction.
• Whether Fitbit’s products practiced every limitation of the asserted claims.
• Whether the patents were anticipated or obvious under 35 U.S.C. §§ 102 or 103.
• Whether the claims would survive a later § 101 motion based on a developed factual record.
• Whether the parties would resolve the dispute through settlement or licensing.

The Federal Circuit’s ruling increased Cellspin’s litigation leverage because the patents could no longer be eliminated solely through the initial pleading-stage eligibility challenge.

Were there Paragraph IV challenges or Orange Book listings?

No Orange Book or Paragraph IV issue was central to this dispute.

Cellspin v. Fitbit was a patent infringement case involving consumer wearable technology and connected-device systems. It was not an ANDA case involving an FDA-listed drug, a generic-drug certification, or a Hatch-Waxman exclusivity dispute. The asserted patents were not being enforced through the pharmaceutical Orange Book framework.

As a result:

Issue	Cellspin v. Fitbit
FDA Orange Book listing	Not applicable
Paragraph IV certification	Not applicable
Generic-drug launch	Not applicable
Biosimilar challenge	Not applicable
Hatch-Waxman stay	Not applicable
Connected-device infringement	Central issue

What patent litigation risks did Fitbit face?

After reversal, Fitbit faced continued exposure to infringement claims covering products that combine wearable sensors, mobile-device applications, and cloud services.

The principal risks were:

1. Continued discovery into the technical operation of Fitbit products.
2. Claim-construction disputes over communication sequencing and data-transfer limitations.
3. Expert testimony concerning whether the accused system performed the claimed steps.
4. Renewed invalidity arguments under §§ 101, 102, and 103.
5. Potential damages exposure for products sold during the relevant patent period.
6. Settlement pressure if the asserted claims survived claim construction and summary judgment.

The case did not establish that all Fitbit products infringed. Infringement would depend on the specific operation of the accused products and the scope of the asserted claims.

How strong was Cellspin’s patent position after the ruling?

Cellspin’s position improved materially at the pleadings stage but remained untested on the merits.

Strengths

• The Federal Circuit accepted that the claims plausibly addressed a specific wireless communications problem.
• The claims involved an ordered combination rather than only a desired result.
• The specification supplied technical context supporting Cellspin’s inventive-concept allegations.
• Early dismissal under § 101 was unavailable on the appellate record.

Weaknesses

• The Federal Circuit did not hold that the patents were valid.
• The patents relied on combinations of known hardware components.
• The claims could still face obviousness challenges.
• Infringement depended on detailed product architecture and claim construction.
• The decision was limited to the pleading record.

The strongest litigation value lay in the ability to proceed into discovery. The decision did not establish a broad rule that wireless sensor patents are categorically eligible.

What generic launch or biosimilar risks existed?

Generic-drug and biosimilar launch risks were not relevant. Fitbit sold consumer electronics and connected-device products, not FDA-approved drugs or biologics.

The comparable commercial risk was product redesign or technical workarounds. A defendant facing sensor-communication claims may attempt to alter:

• The order in which sensor and mobile-device communications are established.
• Whether data is transmitted through a mobile device or directly to a server.
• The timing of sensor activation and data capture.
• The application-layer communication protocol.
• The use of cloud processing or local processing.

Whether a redesign avoids infringement would depend on the language of the asserted claims, including any limitations requiring a particular sequence or communication relationship.

What licensing and settlement issues were relevant?

The public appellate decision resolved the pleading-stage eligibility issue but did not disclose a licensing agreement or settlement between Cellspin and Fitbit.

The reversal created a conventional settlement framework. Cellspin could seek a license covering Fitbit products, a lump-sum payment, running royalties, or a covenant not to sue. Fitbit could seek dismissal, noninfringement terms, patent releases, or a technology-specific license.

The value of any settlement would depend on:

• The number of accused products.
• Sales during the patent damages period.
• The remaining patent term.
• The probability of surviving claim construction.
• The scope of any noninfringing product redesign.
• The outcome of invalidity analysis under §§ 101, 102, and 103.

No settlement term should be inferred from the Federal Circuit reversal alone.

How does Cellspin v. Fitbit compare with other software-patent cases?

Cellspin is closer to cases recognizing a technical improvement in computer functionality than to cases invalidating claims that merely automate a business process.

In Enfish LLC v. Microsoft Corp., the Federal Circuit held that claims directed to a specific self-referential database structure were not abstract at Alice step one because they improved computer functionality. In McRO, Inc. v. Bandai Namco Games America Inc., the court upheld claims using specific rules to automate facial animation. In contrast, cases such as Electric Power Group, LLC v. Alstom S.A. treated generalized information collection, analysis, and display as abstract.

Cellspin did not necessarily place the claims outside the abstract-idea category at step one. Its importance lies in the court’s acceptance that the ordered combination could plausibly provide an inventive concept at step two. [2-4]

What are the business implications of Cellspin v. Fitbit?

The decision has practical implications for both patent owners and connected-device companies.

Patent owners should draft and prosecute claims that identify:

• A specific communications sequence.
• A defined relationship among sensors, mobile devices, and servers.
• A technical problem caused by conventional wireless architectures.
• A measurable improvement in data transfer, timing, reliability, or processing.
• Structural and operational limitations that distinguish the claim from generic data transmission.

Accused companies should preserve technical evidence concerning:

• Product communication protocols.
• Mobile-application functionality.
• Sensor pairing and activation.
• Cloud-service architecture.
• Alternative implementations.
• Prior-art systems and industry standards.

For investors and licensing teams, the principal valuation point is that the Federal Circuit decision preserved litigation optionality. It did not convert the patents into a proven exclusionary asset. The commercial value depended on subsequent claim construction, invalidity analysis, infringement proof, and the remaining patent term.

Key Takeaways

• Cellspin Soft appealed after the district court dismissed its patent claims under § 101.
• The asserted patents covered wireless sensor, mobile-device, and server communications.
• The Federal Circuit reversed the dismissal in Case No. 22-2025.
• The court held that Cellspin plausibly alleged an inventive concept based on the claimed ordered combination and technical communications sequence.
• The ruling was procedural and did not establish infringement or final patent validity.
• Fitbit remained able to pursue noninfringement, anticipation, obviousness, and later eligibility defenses.
• Orange Book listings, Paragraph IV challenges, generic-drug entry, and biosimilar risk were not applicable.
• The decision increased Cellspin’s leverage by allowing the dispute to proceed into discovery and claim construction.

Frequently Asked Questions

Did Cellspin win the patent case against Fitbit?

No. Cellspin won the Federal Circuit appeal concerning dismissal under § 101. The appellate court did not enter a final infringement judgment or hold that the patents were valid.

What did Fitbit argue in the Federal Circuit?

Fitbit argued that Cellspin’s claims were directed to the abstract idea of collecting and transmitting sensor data and lacked an inventive concept. The Federal Circuit rejected dismissal at the pleading stage.

Can Fitbit still challenge the Cellspin patents?

Yes. Fitbit could pursue noninfringement and invalidity defenses, including challenges under §§ 101, 102, and 103, subject to the later procedural record.

Did the case involve Fitbit’s wearable devices?

Yes. The dispute concerned wireless sensor and data-communication technology relevant to connected wearable products and associated mobile and cloud systems.

Does the Cellspin decision establish that all IoT patents are patent-eligible?

No. The ruling was fact-specific and procedural. It held that Cellspin plausibly alleged a patent-eligible inventive concept for the asserted claims, not that Internet-of-Things patents generally satisfy § 101.

References

1. Cellspin Soft, Inc. v. Fitbit, Inc., No. 22-2025, slip op. (Fed. Cir. 2023).

2. Alice Corp. Pty. Ltd. v. CLS Bank International, 573 U.S. 208 (2014).

3. Enfish, LLC v. Microsoft Corp., 822 F.3d 1327 (Fed. Cir. 2016).

4. McRO, Inc. v. Bandai Namco Games America Inc., 837 F.3d 1299 (Fed. Cir. 2016).